Source: Frontiers in Immunology. Unidades: FFCLRP, FCFRP, EERP, FMRP
Subjects: CORONAVIRUS, SISTEMA IMUNE, INFLAMAÇÃO, PULMÃO, IMUNOPATOLOGIA
ABNT
FRAGA-SILVA, Thais Fernanda de Campos et al. COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes. Frontiers in Immunology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.599736. Acesso em: 18 nov. 2024.APA
Fraga-Silva, T. F. de C., Maruyama, S. R., Sorgi, C. A., Russo, E. M. de S., Fernandes, A. P. M., Cardoso, C. R. de B., et al. (2021). COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes. Frontiers in Immunology, 11. doi:10.3389/fimmu.2020.599736NLM
Fraga-Silva TF de C, Maruyama SR, Sorgi CA, Russo EM de S, Fernandes APM, Cardoso CR de B, Faccioli LH, Dias-Baruffi M, Bonato VLD. COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes [Internet]. Frontiers in Immunology. 2021 ; 11[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fimmu.2020.599736Vancouver
Fraga-Silva TF de C, Maruyama SR, Sorgi CA, Russo EM de S, Fernandes APM, Cardoso CR de B, Faccioli LH, Dias-Baruffi M, Bonato VLD. COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes [Internet]. Frontiers in Immunology. 2021 ; 11[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fimmu.2020.599736